HMDB0002451 | 7b,12a-Dihydroxycholanoic acid | 84413-81-0 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0000514 | Allochenodeoxycholic acid | 15357-34-3 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0000505 | Allocholic acid | 2464-18-8 | | C24H40O5 | 408.579 408.287574388 | Not Available |
HMDB0000478 | Allodeoxycholic acid | 1912-55-6 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0000381 | Allolithocholic acid | 2276-94-0 | | C24H40O3 | 376.5726 376.297745146 | Not Available |
HMDB0000506 | alpha-Muricholic acid | 2393-58-0 | | C24H40O5 | 408.579 408.287574388 | Not Available |
HMDB0002082 | Bisnorcholic acid | | | C22H36O5 | 380.5182 380.256274262 | Not Available |
HMDB0014699 | Bosentan | 147536-97-8 | | C27H29N5O6S | 551.614 551.183854375 | - Fattinger K, Funk C, Pantze M, Weber C, Reichen J, Stieger B, Meier PJ: The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther. 2001 Apr;69(4):223-31. [PubMed:11309550 ]
|
HMDB0000518 | Chenodeoxycholic acid | 474-25-9 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0002586 | Chenodeoxycholic acid 3-sulfate | 59132-32-0 | | C24H40O7S | 472.635 472.249474324 | Not Available |
HMDB0000545 | Chenodeoxycholic acid disulfate | 60262-91-1 | | C24H40O10S2 | 552.698 552.20628888 | Not Available |
HMDB0002522 | Chenodeoxycholic acid sulfate | 59132-31-9 | | C24H40O7S | 472.635 472.249474324 | Not Available |
HMDB0006898 | Chenodeoxyglycocholic acid | | | C26H43NO5 | 449.6233 449.314123491 | Not Available |
HMDB0014620 | Chlorpromazine | 50-53-3 | | C17H19ClN2S | 318.864 318.095747015 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0000619 | Cholic acid | 81-25-4 | | C24H40O5 | 408.5714 408.28757439 | - Green RM, Hoda F, Ward KL: Molecular cloning and characterization of the murine bile salt export pump. Gene. 2000 Jan 4;241(1):117-23. [PubMed:10607905 ]
- Mita S, Suzuki H, Akita H, Stieger B, Meier PJ, Hofmann AF, Sugiyama Y: Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump. Am J Physiol Gastrointest Liver Physiol. 2005 Jan;288(1):G159-67. Epub 2004 Aug 5. [PubMed:15297262 ]
- Hartmann G, Cheung AK, Piquette-Miller M: Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther. 2002 Oct;303(1):273-81. [PubMed:12235261 ]
|
HMDB0014644 | Cimetidine | 51481-61-9 | | C10H16N6S | 252.339 252.115715232 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0014983 | Clofazimine | 2030-63-9 | | C27H22Cl2N4 | 473.396 472.122152138 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0000601 | Coprocholic acid | 547-98-8 | | C27H46O5 | 450.6511 450.334524582 | Not Available |
HMDB0014832 | Daunorubicin | 20830-81-3 | | C27H29NO10 | 527.5199 527.179146153 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
- Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD: Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol. 2000 Jan;57(1):24-35. [PubMed:10617675 ]
|
HMDB0000626 | Deoxycholic acid | 83-44-3 | | C24H40O4 | 392.572 392.292659768 | - Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, Venkataramanan R, Cai H, Sinal CJ, Gonzalez FJ, Schuetz JD: Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem. 2001 Oct 19;276(42):39411-8. Epub 2001 Aug 16. [PubMed:11509573 ]
|
HMDB0000659 | Deoxycholic acid disulfate | 67030-51-7 | | C24H40O10S2 | 552.698 552.20628888 | Not Available |
HMDB0015364 | Dexamethasone | 50-02-2 | | C22H29FO5 | 392.4611 392.199902243 | - Fardel O, Payen L, Courtois A, Vernhet L, Lecureur V: Regulation of biliary drug efflux pump expression by hormones and xenobiotics. Toxicology. 2001 Oct 5;167(1):37-46. [PubMed:11557128 ]
|
HMDB0015132 | Doxorubicin | 23214-92-8 | | C27H29NO11 | 543.5193 543.174060775 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0014831 | Fluorescein | 2321-07-5 | | C20H12O5 | 332.3063 332.068473494 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0015570 | Fusidic Acid | 6990-06-3 | | C31H48O6 | 516.7092 516.345089268 | - Bode KA, Donner MG, Leier I, Keppler D: Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate. Biochem Pharmacol. 2002 Jul 1;64(1):151-8. [PubMed:12106615 ]
|